The New York City-based orthopedics provider calls all patients before a procedure to collect patient-reported outcomes measures. The information is used to help clinicians better understand and treat their patients.
The CMS on Thursday released its annual list of measures under consideration for Medicare's quality reporting and value-based purchasing programs. The number of measures under review is much smaller compared to last year when CMS considered nearly 100 measures.
U.S. health authorities will crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received little oversight.
A new JAMA study found that as hospitals reduced readmission rates for heart failure patients as part of the CMS' readmissions program, mortality rates for those patients rose.
Patient outcomes don't suffer when surgeons perform critical parts of the procedure and then depart for another underway, according to a new JAMA study.
State officials worry that the hospital's decision to only accept patients who seek voluntary psychiatric treatment to its 16-bed behavioral health center — not patients who are involuntarily ordered to such care by the courts — might lead other private hospitals to do the same.
Oncologists often feel pressure from breast cancer patients to provide longer and more costly treatments even when the patient is eligible for less aggressive options, a new study revealed.
Reducing the frequency of laboratory tests can improve patient satisfaction and reduce cost without harming patient outcomes, according to a recent study published in JAMA.
New research raises the idea that clinical decisionmaking can be improved with interventions that focus more on the human traits that influence our choices.
Accountable care organizations are slowly entering more risk-based contracts, but delivery system reform isn't keeping pace with payment model changes.
With more people surviving cancer, programs to help them stay healthy after treatment are growing, but are still concentrated at large, expensive academic centers.
As a hospital leader, you've likely considered how to maximize the value of your Hospital Medicine (HM) program. When managed well, the program can deliver a significant return on investment, influencing many economic and behavioral value drivers, including length of stay, case mix index,...